CHS INC — M&A Activity 2007

Nov 29, 2007

8-K 1 htm_24093.htm LIVE FILING CoverPageHeader start html PUBLIC "-//W3C//DTD HTML 3.2//EN" CHS Inc. (Form: 8-K)

CoverPageHeader end CoverPageTitle START

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): November 29, 2007

CoverPageTitle END CoverPageRegistrant START

CHS Inc. ______ (Exact name of registrant as specified in its charter)

Minnesota	0-50150	41-0251095
___ (State or other jurisdiction	_______ (Commission	__ (I.R.S. Employer
of incorporation)	File Number)	Identification No.)
5500 Cenex Drive, Inver Grove Heights, Minnesota		55077
_________ (Address of principal executive offices)		_____ (Zip Code)

Registrant’s telephone number, including area code: 651-355-6000

Not Applicable __________ Former name or former address, if changed since last report

CoverPageRegistrant END

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

PageBreak START

Top of the Form

PageBreak END Item START

Item 8.01 Other Events.

On November 29, 2007, US BioEnergy Corporation and VeraSun Energy Corporation announced that they have entered into a merger agreement. The merger is expected to close during the first quarter of calendar 2008, pending shareholder approval, anti-trust regulatory clearance and the completion of other customary conditions. CHS Inc. owns approximately 20% of the outstanding shares of common stock of US BioEnergy Corporation.

Item END Item START

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits 99.1 Press release dated November 29, 2007

Item END

PageBreak START

Top of the Form

PageBreak END SignatureHeader START

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

SignatureHeader END Signature START

/s/ John Schmitz
Name: John Schmitz
Title: Executive Vice President and Chief Financial Officer

Signature END PageBreak START

Top of the Form

PageBreak END

Exhibit Index

Exhibit No.	Description
99.1	Press release dated November 29, 2007

HTMLFooter START HTMLFooter END